These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1725017)

  • 1. Preservation of endothelial function by ramipril in rabbits on a long-term atherogenic diet.
    Becker RH; Wiemer G; Linz W
    J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S110-5. PubMed ID: 1725017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of endothelium-derived bradykinin in the control of vascular tone.
    Hecker M; Dambacher T; Busse R
    J Cardiovasc Pharmacol; 1992; 20 Suppl 9():S55-61. PubMed ID: 1282631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the antiatherogenic effects of isradipine and ramipril in cholesterol-fed rabbits: II. Effect on regression of atherosclerosis and restoration of endothelial function.
    Riezebos J; Vleeming W; Beems RB; van Amsterdam JG; Meijer GW; de Wildt DJ; Porsius AJ; Wemer J
    J Cardiovasc Pharmacol; 1994 Mar; 23(3):424-31. PubMed ID: 7515986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of chronic treatment with the vasopeptidase inhibitor AVE 7688 and ramipril on endothelial function in atherogenic diet rabbits.
    Weckler N; Leitzbach D; Kalinowski L; Malinski T; Busch AE; Linz W
    J Renin Angiotensin Aldosterone Syst; 2003 Sep; 4(3):191-6. PubMed ID: 14608526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the antiatherogenic effects of isradipine and ramipril in cholesterol-fed rabbits: I. Effect on progression of atherosclerosis and endothelial dysfunction.
    Riezebos J; Vleeming W; Beems RB; van Amsterdam JG; Meijer GW; de Wildt DJ; Porsius AJ; Wemer J
    J Cardiovasc Pharmacol; 1994 Mar; 23(3):415-23. PubMed ID: 7515985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ramipril prevents impaired endothelium-dependent relaxation in arteries from rabbits fed an atherogenic diet.
    Finta KM; Fischer MJ; Lee L; Gordon D; Pitt B; Webb RC
    Atherosclerosis; 1993 May; 100(2):149-56. PubMed ID: 8357348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Converting enzyme inhibitor-stimulated formation of nitric oxide and prostacyclin in endothelial cells from bovine aorta is mediated by endothelium-derived bradykinin.
    Wiemer G; Schölkens BA; Becker RH
    Agents Actions Suppl; 1992; 38 ( Pt 3)():196-200. PubMed ID: 1334350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ramiprilat enhances endothelial autacoid formation by inhibiting breakdown of endothelium-derived bradykinin.
    Wiemer G; Schölkens BA; Becker RH; Busse R
    Hypertension; 1991 Oct; 18(4):558-63. PubMed ID: 1655653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelium-derived bradykinin: implications for angiotensin-converting enzyme-inhibitor therapy.
    Busse R; Fleming I; Hecker M
    J Cardiovasc Pharmacol; 1993; 22 Suppl 5():S31-6. PubMed ID: 7508049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin-converting enzyme inhibitors unmask endogenous kinin production by bovine coronary artery endothelium.
    Hecker M; Bara AT; Busse R
    Eur Heart J; 1993 Nov; 14 Suppl I():161-3. PubMed ID: 8293768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of bradykinin to the cardiovascular effects of ramipril.
    Linz W; Wiemer G; Schölkens BA
    J Cardiovasc Pharmacol; 1993; 22 Suppl 9():S1-8. PubMed ID: 7514234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term low-dose angiotensin converting enzyme inhibitor treatment increases vascular cyclic guanosine 3',5'-monophosphate.
    Gohlke P; Lamberty V; Kuwer I; Bartenbach S; Schnell A; Linz W; Schölkens BA; Wiemer G; Unger T
    Hypertension; 1993 Nov; 22(5):682-7. PubMed ID: 8225528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ACE inhibitor effect on bradykinin metabolism in the vascular wall.
    Gohlke P; Bünning P; Bönner G; Unger T
    Agents Actions Suppl; 1992; 38 ( Pt 3)():178-85. PubMed ID: 1462857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic angiotensin-converting enzyme inhibition and endothelial function of rat aorta.
    Berkenboom G; Brékine D; Unger P; Grosfils K; Staroukine M; Fontaine J
    Hypertension; 1995 Nov; 26(5):738-43. PubMed ID: 7591012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of endothelial autacoid formation by inhibitors of angiotensin-converting enzyme.
    Hecker M; Benzing T; Busse R
    Agents Actions Suppl; 1992; 38 ( Pt 3)():163-70. PubMed ID: 1281378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
    De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
    Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasopeptidase inhibition improves insulin sensitivity and endothelial function in the JCR:LA-cp rat.
    Russell JC; Kelly SE; Schäfer S
    J Cardiovasc Pharmacol; 2004 Aug; 44(2):258-65. PubMed ID: 15243308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of hypercholesterolemia on the contractions to angiotensin II in the isolated aorta and iliac artery of the rabbit: role of arachidonic acid metabolites.
    Dam JP; Vleeming W; Riezebos J; Post MJ; Porsius AJ; Wemer J
    J Cardiovasc Pharmacol; 1997 Jul; 30(1):118-23. PubMed ID: 9268230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of the angiotensin converting enzyme inhibitor ramipril on calcium (Ca2+) kinetics in smooth muscle cells].
    Meyer-Lehnert H; Jahnecke C; Kappes-Horn K; Kramer HJ
    Klin Wochenschr; 1991; 69 Suppl 24():45-9. PubMed ID: 1650862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin converting enzyme inhibitors and atherosclerosis.
    Andersson RG; Jacobsson L; Persson K
    J Physiol Pharmacol; 1994 Mar; 45(1):13-25. PubMed ID: 8043902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.